This track will explore the latest innovations in diagnostic technologies for infectious diseases, focusing on rapid and accurate detection methods. Emphasis will be placed on the integration of molecular diagnostics and point-of-care testing in clinical settings.

This session will address the growing threat of antimicrobial resistance, examining its implications for clinical practice and public health. Discussions will include strategies for stewardship, novel therapeutic approaches, and the role of policy in combating resistance.

This track will highlight the design and implementation of clinical trials aimed at improving treatment protocols for infectious diseases. Participants will discuss regulatory challenges, ethical considerations, and the impact of trial results on clinical practice.

This session will focus on effective infection control measures within healthcare facilities to prevent the spread of infectious diseases. Topics will include best practices, surveillance systems, and the role of healthcare workers in maintaining safety.

This track will examine current and emerging therapeutic options for the treatment of infectious diseases, including antiviral and antibiotic therapies. Discussions will also cover the development of treatment guidelines and personalized medicine approaches.

This session will explore the role of vaccination in controlling infectious diseases and its impact on public health outcomes. Participants will discuss vaccine development, distribution challenges, and community engagement in immunization efforts.